Max Healthcare Institute Limited — PPTs, 31-05-2025: Investor Presentation

1. Financial Highlights:

Max Healthcare’s network delivered ₹8,667 Cr net revenue in FY25, up 27% YoY, with operating EBITDA at ₹2,319 Cr (26.8% margin). Profit after tax rose to ₹1,336 Cr (15.4% margin), reflecting strong profitability despite higher overheads and finance costs from acquisitions. Q4 FY25 recorded 29% revenue growth and 26% EBITDA growth YoY. Shareholders’ equity improved to ₹10,533 Cr with manageable net debt (~₹1,576 Cr). ROCE stood near 35%, highlighting effective capital use.

2. Strategic Initiatives & Growth Drivers:

Max plans to nearly double bed capacity over 4-5 years—~2,500 beds from brownfield and ~1,000 beds via greenfield projects in key metros including Gurgaon and Lucknow. Focus areas include tower specialities, utilization ramp-up, digital expansion (Max MyHealth platform), and asset-light ‘built-to-suit’ hospitals. Diagnostic (Max Lab) and homecare (Max@Home) businesses are growing rapidly with 34-45%+ CAGR since FY18, enhancing patient reach and service breadth.

3. Business Developments:

Acquisitions of Jaypee Healthcare (Noida), Sahara Hospital (Lucknow), and Alexis Hospital (Nagpur) have boosted scale, showing 41% revenue and 96% EBITDA growth combined YoY. The greenfield asset-light Dwarka hospital achieved breakeven in six months. Clinical advancements include new robotic surgeries, transplant programs, oncology expansions, and diagnostics infrastructure growth.

4. Market Position & Competitive Advantage:

Max leads the Indian hospital industry by market cap and ranks top two by revenue and EBITDA. Dominant in premium, high ARPOB metros like Delhi NCR and Mumbai, it benefits from advanced quaternary care, research tie-ups, and strong academic collaborations. Large metro bed presence plus rising insurance penetration and medical tourism provide pricing and volume advantages.

5. Investor Implications:

Strong financials, focused capital deployment, and asset-light expansion underpin positive growth potential. Efficient acquisition integration and rapid scaling of digital and adjacent services reduce execution risks. Margin sustainability amid rising overheads and bed ramp-up pace is a key factor to watch. Overall, Max Healthcare appears well placed for long-term value creation through metro-focused growth and diversified healthcare offerings.